Irina Reiter
Haifa, HA 31096, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
Journal: Journal of cellular and molecular medicine
Published: October 28, 2020
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Journal: Journal of cellular and molecular medicine
Published: October 07, 2018
Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
Journal: Stem cell research
Published: February 26, 2018
CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Journal: Heart rhythm
Published: July 08, 2017
Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
Journal: Journal of cellular and molecular medicine
Published: May 23, 2017
The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats.
Journal: Pharmacology research & perspectives
Published: July 10, 2016
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Journal: Journal of cellular and molecular medicine
Published: November 10, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026